PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions

Oral Oncology

Volumn 49, Issue 2, 2013, Pages 144-151

  Szczepanski, Miroslaw J ^a,b   Deleo, Albert B ^d   Łuczak, Michał ^a   Molinska Glura, Marta ^a   Misiak, Jan ^a   Szarzynska, Bronislawa ^a   Dworacki, Grzegorz ^a   Zagor, Mariola ^b   Rozwadowska, Natalia ^c   Kurpisz, MacIej ^c   Krzeski, Antoni ^b   Kruk Zagajewska, Aleksandra ^a   Kopec, Tomasz ^a   Banaszewski, Jacek ^a   Whiteside, Theresa L ^d  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c INSTITUTE OF HUMAN GENETICS   (Poland)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Clinical association; Head and neck cancer; Immunohistochemistry; Larynx dysplasia; Oral mucosa; PRAME overexpression

Indexed keywords

MESSENGER RNA; PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA ANTIGEN; RETINOID; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PREVENTION; CANCER PROGNOSIS; CANCER SIZE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPLASIA; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; ORAL BIOPSY; PATIENT SELECTION; PRECANCER; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHEMOPREVENTION; DISEASE PROGRESSION; DNA PRIMERS; FEMALE; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETINOIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84872283380     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.08.005     Document Type: Article

References (37)

1. A. Forastiere, W. Koch, A. Trotti, and D. Sidransky Head and neck cancer N Engl J Med 345 2001 1890 1900
2. J.H. Lorch, O. Goloubeva, R.I. Haddad, K. Cullen, N. Sarlis, and R. Tishler Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial Lancet Oncol 12 2011 153 159
3. M.R. Posner, D.M. Hershock, C.R. Blajman, E. Mickiewicz, E. Winquist, and V. Gorbounova Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715
4. A. Argiris, S.C. Lee, T. Feinstein, S. Thomas, B.F.T. Branstetter, and R. Seethala Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer Oral Oncol 47 2011 961 966
5. C. Calli, A. Calli, E. Pinar, S. Oncel, and B. Tatar Prognostic significance of p63, p53 and ki67 expression in laryngeal basaloid squamous cell carcinomas B-ENT 7 2011 37 42
6. K.J. Cullen, L. Schumaker, N. Nikitakis, O. Goloubeva, M. Tan, and N.J. Sarlis Beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial J Clin Oncol 27 2009 6222 6228
7. K.D. Lee, H.S. Lee, and C.H. Jeon Body fluid biomarkers for early detection of head and neck squamous cell carcinomas Anticancer Res 31 2011 1161 1167
8. Y. Wu, M.R. Posner, L.M. Schumaker, N. Nikitakis, O. Goloubeva, and M. Tan Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial Cancer 118 2011 1811 1817
9. C.J. Langer Exploring biomarkers in head and neck cancer Cancer 2012
10. J.C. Rhee, F.R. Khuri, and D.M. Shin Advances in chemoprevention of head and neck cancer Oncologist 9 2004 302 311
11. H. Ikeda, B. Lethe, F. Lehmann, N. van Baren, J.F. Baurain, and C. de Smet Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor Immunity 6 1997 199 208
12. D. Atanackovic, T. Luetkens, B. Kloth, G. Fuchs, Y. Cao, and Y. Hildebrandt Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia Am J Hematol 86 2011 918 922
13. M.T. Epping, and R. Bernards A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer Cancer Res 66 2006 10639 10642
14. C. Zou, J. Shen, Q. Tang, Z. Yang, J. Yin, and Z. Li Cancer-testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosis Cancer 118 2011 1845 1855
15. M.T. Epping, L. Wang, M.J. Edel, L. Carlee, M. Hernandez, and R. Bernards The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling Cell 122 2005 835 847
16. L.J. Gudas, and J.A. Wagner Retinoids regulate stem cell differentiation J Cell Physiol 226 2011 322 330
17. P. Dolle Developmental expression of retinoic acid receptors (RARs) Nucl Recept Signal 7 2009 e006
18. M. Mark, N.B. Ghyselinck, and P. Chambon Function of retinoic acid receptors during embryonic development Nucl Recept Signal 7 2009 e002
19. A.L. Means, and L.J. Gudas The roles of retinoids in vertebrate development Annu Rev Biochem 64 1995 201 233
20. S.J. Freemantle, K.H. Dragnev, and E. Dmitrovsky The retinoic acid paradox in cancer chemoprevention J Natl Cancer Inst 98 2006 426 427
21. V.A. Papadimitrakopoulou, J.J. Lee, W.N. William Jr., J.W. Martin, M. Thomas, and E.S. Kim Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy J Clin Oncol 27 2009 599 604
22. D.S. Heo, C. Snyderman, S.M. Gollin, S. Pan, E. Walker, and R. Deka Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines Cancer Res 49 1989 5167 5175
23. C.D. Lansford, R. Grenman, H. Bier, K.D. Somers, S.Y. Kim, and T.L. Whiteside Head and neck cancers. Human cell culture: cancer cell lines Part 2 vol. 2 1999 Kluwer Academic Publishers Dordrecht p. 185-255
24. C.J. Lin, J.R. Grandis, T.E. Carey, S.M. Gollin, T.L. Whiteside, and W.M. Koch Head and neck squamous cell carcinoma cell lines: established models and rationale for selection Head Neck 29 2007 163 188
25. M. Meissner, T.E. Reichert, M. Kunkel, W. Gooding, T.L. Whiteside, and S. Ferrone Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome Clin Cancer Res 11 2005 2552 2560
26. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159
27. M. Szajnik, M.J. Szczepanski, M. Czystowska, E. Elishaev, M. Mandapathil, and E. Nowak-Markwitz TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer Oncogene 28 2009 4353 4363
28. M.J. Szczepanski, M. Czystowska, M. Szajnik, M. Harasymczuk, M. Boyiadzis, and A. Kruk-Zagajewska Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack Cancer Res 69 2009 3105 3113
29. M. Gry, R. Rimini, S. Stromberg, A. Asplund, F. Ponten, and M. Uhlen Correlations between RNA and protein expression profiles in 23 human cell lines BMC Genomics 10 2009 365
30. R. Parker, and H. Song The enzymes and control of eukaryotic mRNA turnover Nat Struct Mol Biol 11 2004 121 127
31. C. Visus, Y. Wang, A. Lozano-Leon, R.L. Ferris, S. Silver, and M.J. Szczepanski Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8(+) T cells Clin Cancer Res 17 2011 6174 6184
32. T.L. Whiteside Immunobiology and immunotherapy of head and neck cancer Curr Oncol Rep 3 2001 46 55
33. T.L. Whiteside Immunobiology of head and neck cancer Cancer Metastasis Rev 24 2005 95 105
34. T. Sudo, T. Kuramoto, S. Komiya, A. Inoue, and K. Itoh Expression of MAGE genes in osteosarcoma J Orthop Res 15 1997 128 132
35. E.F. Velazquez, A.A. Jungbluth, M. Yancovitz, S. Gnjatic, S. Adams, and D. O'Neill Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)-correlation with prognostic factors Cancer Immun 7 2007 11
36. C. Cuffel, J.P. Rivals, Y. Zaugg, S. Salvi, W. Seelentag, and D.E. Speiser Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma Int J Cancer 128 2011 2625 2634
37. D.L. Figueiredo, R.C. Mamede, R. Proto-Siqueira, L. Neder, W.A. Silva Jr., and M.A. Zago Expression of cancer testis antigens in head and neck squamous cell carcinomas Head Neck 28 2006 614 619